The origin and development of Banff classification on allograft pathology and its effects in promoting organ transplantation

Guo Hui; Chen Gang

doi:10.3969/j.issn.1674-7445.2021.01.003

Volume 12 Issue 1

Jan. 2021

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2021 > 12(1): 15-22

Guo Hui, Chen Gang. The origin and development of Banff classification on allograft pathology and its effects in promoting organ transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 15-22. doi: 10.3969/j.issn.1674-7445.2021.01.003

Citation:

PDF( 807 KB)

The origin and development of Banff classification on allograft pathology and its effects in promoting organ transplantation

doi: 10.3969/j.issn.1674-7445.2021.01.003

Guo Hui,
Chen Gang^,

Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, Key Laboratory of Organ Transplantation of National Health Commission of China, Key Laboratory of Organ Transplantation of Chinese Academy of Medical Sciences, Wuhan 430030, China

More Information

Corresponding author: Chen Gang, Email: gchen@tjh.tjmu.edu.cn
Received Date: 2020-11-10
Available Online: 2021-01-19
Publish Date: 2021-01-19

Abstract

Abstract

The Banff conference on allograft pathology (Banff conference) and the establishment of Banff classification on allograft pathology (Banff classification) are milestones in the development of international allograft pathology. At present, all organ transplantation centers around the world routinely perform pathological diagnosis by biopsy of the transplant kidney according to Banff classification. Subsequently, the consensus process and update mode of Banff classification for transplant kidney was quickly extended to transplant heart, lung, liver, pancreas, and small intestine, etc. The Banff conference has not only become a thematic meeting that includes the pathology study and discussion of various transplant organs, but also gradually developed unified diagnostic standard for the biopsy of each transplant organ, which better promoted the accurate diagnosis and treatment of complications after organ transplantation. This article summarized the history of international allograft pathology research, the Banff conference and Banff classification in promoting organ transplantation, which aimed to provide a reference for the smooth development of clinical organ transplantation.
- Allograft pathology,
- Organ transplantation,
- Banff conference,
- Biopsy,
- Diagnostic classification of pathology,
- Antibody-mediated rejection,
- T cell-mediated rejection,
- C4d

FullText(HTML)

References(60)

References

[1]	WILLIAMSON CS. Further studies on the transplantation of the kidney[J]. J Urol, 1926, 16(4):231-254. doi: 10.1016/S0022-5347(17)73405-2
[2]	KREIS H, NOËL LH, LEGENDRE C. The first transplant kidney biopsy ever performed[J]. Am J Transplant, 2013, 13(5):1367-1368. DOI: 10.1111/ajt.12214.
[3]	KISSMEYER-NIELSEN F, OLSEN S, PETERSEN VP, et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells[J]. Lancet, 1966, 2(7465):662-665. DOI: 10.1016/s0140-6736(66)92829-7.
[4]	PORTER KA. Morphological aspects of renal homograft rejection[J]. Br Med Bull, 1965, 21:171-175. DOI: 10.1093/oxfordjournals.bmb.a070388.
[5]	PORTER KA. Rejection in treated renal allografts[J]. J Clin Pathol, 1967, 20:518-534.
[6]	PORTER KA, RENDALL JM, STOLINSKI C, et al. Light and electron microscopic study of biopsies from thirty-three human renal allografts and an isograft 1 3/4-2 1/2 years after transplantation[J]. Ann N Y Acad Sci, 1966, 129(1):615-636. DOI: 10.1111/j.1749-6632.1966.tb12883.x.
[7]	JORDAN SC, MALEKZADEH MH, PENNISI AJ, et al. Accelerated acute rejection of primary renal allografts in pediatric patients[J]. Transplantation, 1980, 30(1):5-8. DOI: 10.1097/00007890-198007000-00002.
[8]	SOULILLOU JP, DE MOUZON-CAMBON A, DUBOIS C, et al. Immunological studies of eluates of 83 rejected kidneys: screening of antibodies directed against T and B lymphocytes, glomerular and tubular basement membranes, DNA, and IgG[J]. Transplantation, 1981, 32(5):368-374. DOI: 10.1097/00007890-198111000-00005.
[9]	HALLORAN PF, WADGYMAR A, RITCHIE S, et al. The significance of the anti-class I antibody response. Ⅰ. clinical and pathologic features of anti-class I-mediated rejection[J]. Transplantation, 1990, 49(1):85-91. DOI: 10.1097/00007890-199001000-00019.
[10]	HALLORAN PF, SCHLAUT J, SOLEZ K, et al. The significance of the anti-class I response. Ⅱ. clinical and pathologic features of renal transplants with anti-class I-like antibody[J]. Transplantation, 1992, 53(3):550-555. doi: 10.1097/00007890-199203000-00011
[11]	FEUCHT HE, FELBER E, GOKEL MJ, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection[J]. Clin Exp Immunol, 1991, 86(3):464-470. DOI: 10.1111/j.1365-2249.1991.tb02954.x.
[12]	FEUCHT HE, SCHNEEBERGER H, HILLEBRAND G, et al. Capillary deposition of C4d complement fragment and early renal graft loss[J]. Kidney Int, 1993, 43(6):1333-1338. DOI: 10.1038/ki.1993.187.
[13]	COLLINS AB, SCHNEEBERGER EE, PASCUAL MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries[J]. J Am Soc Nephrol, 1999, 10(10):2208-2214. http://europepmc.org/abstract/med/10505698
[14]	BÖHMIG GA, EXNER M, HABICHT A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury[J]. J Am Soc Nephrol, 2002, 13(4):1091-1099. http://www.ncbi.nlm.nih.gov/pubmed/11912271
[15]	BÖHMIG GA, REGELE H, EXNER M, et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption[J]. J Am Soc Nephrol, 2001, 12(11):2482-2489. http://www.ncbi.nlm.nih.gov/pubmed/11675426
[16]	THIRU S, MAHER ER, HAMILTON DV, et al. Tubular changes in renal transplant recipients on cyclosporine[J]. Transplant Proc, 1983, 15:2846-2851. http://www.researchgate.net/publication/290811197_tubular_changes_in_renal_transplant_recipients_on_cyclosporine
[17]	CALNE RY, WHITE DJ, THIRU S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors[J]. Lancet, 1978, 2(8104/8105):1323-1327. DOI: 10.1016/s0140-6736(78)91970-0.
[18]	MIHATSCH MJ, THIEL G, SPICHTIN HP. Morphological findings in kidney transplants after treatment with cyclosporin[J]. Transplant Proc, 1983, 15(4):2821-2835. http://www.researchgate.net/publication/279690992_Morphological_findings_in_kidney_transplants_after_treatment_with_cyclosporin
[19]	MIHATSCH MJ, HELMCHEN U, CASANOVA P, et al. Kidney biopsy findings in cyclosporine-treated patients with insulin-dependent diabetes mellitus[J]. Klin Wochenschr, 1991, 69(8):354-359. DOI: 10.1007/BF02115783.
[20]	NEILD GH, REUBEN R, HARTLEY RB, et al. Glomerular thrombi in renal allografts associated with cyclosporin treatment[J]. J Clin Pathol, 1985, 38(3):253-258. DOI: 10.1136/jcp.38.3.253.
[21]	NIZZE H, MIHATSCH MJ, ZOLLINGER HU, et al. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants[J]. Clin Nephrol, 1988, 30(5):248-260. http://europepmc.org/abstract/MED/3063420
[22]	RANDHAWA PS, SHAPIRO R, JORDAN ML, et al. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. clinical significance and comparison with cyclosporine[J]. Am J Surg Pathol, 1993, 17(1):60-68. DOI: 10.1097/00000478-199301000-00007.
[23]	DEMETRIS AJ, JAFFE R, TZAKIS A, et al. Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers[J]. Transplant Proc, 1989, 21(1 Pt 2):2217-2220.
[24]	DEMETRIS AJ, MURASE N, NAKAMURA K, et al. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection[J]. Semin Liver Dis, 1992, 12(1):51-59. DOI: 10.1055/s-2007-1007376.
[25]	SNOVER DC, FREESE DK, SHARP HL, et al. Liver allograft rejection. an analysis of the use of biopsy in determining outcome of rejection[J]. Am J Surg Pathol, 1987, 11(1):1-10. DOI: 10.1097/00000478-198701000-00001.
[26]	HÜBSCHER S. Diagnosis and grading of liver allograft rejection: a European perspective[J]. Transplant Proc, 1996, 28(1):504-507. http://europepmc.org/abstract/MED/8644330
[27]	Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994[J]. Am J Gastroenterol, 1994, 89(8 Suppl): S177-S181.
[28]	LUDWIG J, WIESNER RH, BATTS KP, et al. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation[J]. Hepatology, 1987, 7(3):476-483. DOI: 10.1002/hep.1840070311.
[29]	WILLIAMS JW, PETERS TG, VERA SR, et al. Biopsy-directed immunosuppression following hepatic transplantation in man[J]. Transplantation, 1985, 39(6): 589-596. DOI: 10.1097/00007890-198506000-00003.
[30]	DEMETRIS AJ, QIAN SG, SUN H, et al. Liver allograft rejection: an overview of morphologic findings[J]. Am J Surg Pathol, 1990, 14 (Suppl 1):49-63. http://europepmc.org/abstract/MED/2183642
[31]	GORDON RD, IWATSUKI S, ESQUIVEL CO, et al. Liver transplantation across ABO blood groups[J]. Surgery, 1986, 100(2):342-348. http://europepmc.org/abstract/MED/3526607
[32]	CAVES PK, STINSON EB, BILLINGHAM M, et al. Percutaneous transvenous endomyocardial biopsy in human heart recipients. experience with a new technique[J]. Ann Thorac Surg, 1973, 16(4):325-336. DOI: 10.1016/s0003-4975(10)65002-3.
[33]	BILLINGHAM ME. Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy[J]. J Heart Transplant, 1990, 9(3 Pt 2):272-276.
[34]	HAMMOND EH, YOWELL RL, NUNODA S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications[J].J Heart Transplant, 1989, 8(6):430-443.
[35]	JOSHI A, MASEK MA, BROWN BW JR, et al. "Quilty" revisited: a 10-year perspective[J]. Hum Pathol, 1995, 26(5):547-557. DOI: 10.1016/0046-8177(95)90252-x.
[36]	URETSKY BF, MURALI S, REDDY PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone[J]. Circulation, 1987, 76(4):827-834. DOI: 10.1161/01.cir.76.4.827.
[37]	NARROD J, KORMOS R, ARMITAGE J, et al. Acute rejection and coronary artery disease in long-term survivors of heart transplantation[J]. J Heart Transplant, 1989, 8(5):418-420. http://europepmc.org/abstract/MED/2795285
[38]	ZERBE T, URETSKY B, KORMOS R, et al. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen[J]. J Heart Lung Transplant, 1992, 11(3 Pt 2):S104-S110. http://www.ncbi.nlm.nih.gov/pubmed/1622988
[39]	MCDONALD K, RECTOR TS, BRAULIN EA, et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection[J]. Am J Cardiol, 1989, 64(5):359-362. DOI: 10.1016/0002-9149(89)90535-3.
[40]	CASTANEDA AR, ARNAR O, SCHMIDT-HABELMAN P, et al. Cardiopulmonary autotransplantation in primates[J]. J Cardiovasc Surg (Torino), 1972, 13(5):523-531. http://www.ncbi.nlm.nih.gov/pubmed/4628834
[41]	STEWART S, CIULLI F, WELLS FC, et al. Pathology of unused donor lungs[J]. Transplant Proc, 1993, 25(1 Pt 2):1167-1168. http://www.ncbi.nlm.nih.gov/pubmed/8442074
[42]	STEWART S, HIGENBOTTAM TW, HUTTER JA, et al. Histopathology of transbronchial biopsies in heart-lung transplantation[J]. Transplant Proc, 1988, 20:764-766. http://www.researchgate.net/publication/316495137_Histopathology_of_transbronchial_biopsies_in_heart-lung_transplantation
[43]	BURKE CM, THEODORE J, DAWKINS KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation[J]. Chest, 1984, 86(6):824-829. DOI: 10.1378/chest.86.6.824.
[44]	SIBLEY RK, SUTHERLAND DER. Pancreas transplantation. an immunohistologic and histopathologic examination of 100 grafts[J]. Am J Pathol, 1987, 128(1):151-170. http://europepmc.org/articles/PMC1899795/
[45]	NAKHLEH RE, GRUESSNER RW, SWANSON PE, et al. Pancreas transplant pathology. a morphologic, immunohistochemical, and electron microscopic comparison of allogeneic grafts with rejection, syngeneic grafts, and chronic pancreatitis[J]. Am J Surg Pathol, 1991, 15(3):246-256. doi: 10.1097/00000478-199103000-00005
[46]	NAKAMURA K, NALESNIK M, JAFFE R, et al. Morphological monitoring of human small bowel allografts[J]. Transplant Proc, 1993, 25(1 Pt 2):1212. http://europepmc.org/articles/PMC2963862
[47]	ROSEMURGY AS, SCHRAUT WH. Small bowel allografts. sequence of histologic changes in acute and chronic rejection[J]. Am J Surg, 1986, 151(4):470-475. DOI: 10.1016/0002-9610(86)90106-6.
[48]	SOLEZ K, RACUSEN LC. The Banff classification revisited[J]. Kidney Int, 2013, 83(2):201-206. DOI: 10.1038/ki.2012.395.
[49]	Banff Foundation for Allograft Pathology[EB/OL]. [2020-11-01]. https://www.banfffoundation.org.
[50]	The Banff Conferences on Allograft Pathology[EB/OL]. [2020-11-01]. https://cybernephrology.ualberta.ca/Banff/.
[51]	SOLEZ K, AXELSEN RA, BENEDIKTSSON H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology[J]. Kidney Int, 1993, 44(2):411-422. DOI: 10.1038/ki.1993.259.
[52]	RACUSEN LC, SOLEZ K, COLVIN RB, et al. The Banff 97 working classification of renal allograft pathology[J]. Kidney Int, 1999, 55(2):713-723. DOI: 10.1046/j.1523-1755.1999.00299.x.
[53]	RACUSEN LC, COLVIN RB, SOLEZ K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection[J]. Am J Transplant, 2003, 3(6):708-714. DOI: 10.1034/j.1600-6143.2003.00072.x.
[54]	SOLEZ K, COLVIN RB, RACUSEN LC, et al. Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') [J]. Am J Transplant, 2007, 7(3):518-526. DOI: 10.1111/j.1600-6143.2006.01688.x.
[55]	SOLEZ K, COLVIN RB, RACUSEN LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions[J]. Am J Transplant, 2008, 8(4):753-760. DOI: 10.1111/j.1600-6143.2008.02159.x.
[56]	SIS B, MENGEL M, HAAS M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups[J]. Am J Transplant, 2010, 10(3):464-471. DOI: 10.1111/j.1600-6143.2009.02987.x.
[57]	MENGEL M, SIS B, HAAS M, et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection[J]. Am J Transplant, 2012, 12(3):563-570. DOI: 10.1111/j.1600-6143.2011.03926.x.
[58]	HAAS M, SIS B, RACUSEN LC, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions[J]. Am J Transplant, 2014, 14(2):272-283. DOI: 10.1111/ajt.12590.
[59]	LOUPY A, HAAS M, ROUFOSSE C, et al. The Banff 2019 kidney meeting report (Ⅰ): updates on and clarification of criteria for T cell- and antibody-mediated rejection[J]. Am J Transplant, 2020, 20(9):2318-2331. DOI: 10.1111/ajt.15898.
[60]	黄亚冰, 郭晖, 钟伟雄.2017年Banff移植病理学会议纪要及移植肾病理诊断分类修订[J].中华器官移植杂志, 2018, 39(9):565-570. DOI: 10.3760/cma.j.issn. 0254-1785.2018.09.011. HUANG YB, GUO H, ZHONG WX. 2017 Banff transplant pathology meeting summary and revised classification of transplant kidney pathology [J]. Chin J Organ Transplant, 2018, 39(9): 565-570. DOI: 10.3760/cma.j.issn.0254-1785.2018.09.011.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (316) PDF downloads(122)

The origin and development of Banff classification on allograft pathology and its effects in promoting organ transplantation

doi: 10.3969/j.issn.1674-7445.2021.01.003

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

The origin and development of Banff classification on allograft pathology and its effects in promoting organ transplantation

doi: 10.3969/j.issn.1674-7445.2021.01.003

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content